Abstract:Introduction: Biomedical applications of nanoparticles (NPs) as enzyme inhibitors have recently come to light. Oxides of metals native to the physiological environment (eg, Fe, Zn, Mg, etc.) are of particular interest-especially the functional consequences of their enzyme interaction. Materials and methods: Here, Fe2O3, zinc oxide (ZnO), magnesium oxide (MgO) and nickel oxide (NiO) NPs are compared to copper (Cu) and boron carbide (B4C) NPs. The functional impact of NP interaction to the model enzyme luciferase is determined by 2-dimensional fluorescence difference spectroscopy (2-D FDS) and 2-dimensional photoluminescence difference spectroscopy (2-D PLDS). By 2-D FDS analysis, the change in maximal intensity and in 2-D FDS area under the curve (AUC) is in the order Cu~B4C>ZnO>NiO>>Fe2O3>MgO. The induced changes in protein conformation are confirmed by tryptic digests and gel electrophoresis. Results: Analysis of possible trypsin cleavage sites suggest that cleavage mostly occurs in the range of residues 112-155 and 372-439, giving a major 45 kDa band. By 2-D PLDS, it is found that B4C NPs completely ablate bioluminescence, while Cu and Fe2O3 NPs yield a unique bimodal negative decay rate, -7.67×103 and -3.50×101 relative light units respectively. Cu NPs, in particular, give a remarkable 271% change in enzyme activity. Molecular dynamics simulations in water predicted that the surfaces of metal oxide NPs become capped with metal hydroxide groups under physiological conditions, while the surface of B4C becomes populated with boronic acid or borinic acid groups. These predictions are supported by the experimentally determined zeta potential. Thin layer chromatography patterns further support this conception of the NP surfaces, where stabilizing interactions were in the order ionic>polar>non-polar for the series tested. Conclusion: Overall the results suggest that B4C and Cu NP functional dynamics on enzyme biochemistry are unique and should be examined further for potential ramifications on other model, physiological or disease-relevant enzymes.

Clearance of nanoparticles from blood: Effects of hydrodynamic size and surface coatings

Exploring and Analyzing the Systemic Delivery Barriers for Nanoparticles

Computational Investigations of the Interaction Between the Cell Membrane and Nanoparticles Coated with a Pulmonary Surfactant.

Mechanistic understanding of in vivo protein corona formation on polymeric nanoparticles and impact on pharmacokinetics

Comparative functional dynamics studies on the enzyme nano-bio interface

Noninvasive monitoring of nanoparticle clearance and aggregation in blood circulation by in vivo flow cytometry

Dose Dependencies and Biocompatibility of Renal Clearable Gold Nanoparticles.

Tailoring Renal Clearance and Tumor Targeting of Ultrasmall Metal Nanoparticles with Particle Density

Cytotoxicity-Related Bioeffects Induced by Nanoparticles: The Role of Surface Chemistry

Nanoparticle Tracking Analysis of Polymer Nanoparticles in Blood Plasma

Clearable Nanoparticles for Cancer Photothermal Therapy

A Minimal PBPK Model Describes the Differential Disposition of Silica Nanoparticles In Vivo

Clearance of Two Organic Nanoparticles from the Brain Via the Paravascular Pathway.

Renal Clearable Noble Metal Nanoparticles: Photoluminescence, Elimination, and Biomedical Applications.

Impact of nanoparticles on human health and disease

Renal Clearable Inorganic Nanoparticles: A New Frontier of Bionanotechnology

Surface Chemistry Governs the Sub-Organ Transfer, Clearance and Toxicity of Functional Gold Nanoparticles in the Liver and Kidney

High‐Efficient Clearable Nanoparticles for Multi‐Modal Imaging and Image‐Guided Cancer Therapy

Size Dependency of Circulation and Biodistribution of Biomimetic Nanoparticles: Red Blood Cell Membrane-Coated Nanoparticles

State of the Art of Silica Nanoparticles: An Overview on Biodistribution and Preclinical Toxicity Studies

Cellular Uptake, Intracellular Trafficking, and Cytotoxicity of Nanomaterials